Screener
Hemab Therapeutics Holdings, Inc. COAG PP&E (Net)
PP&E (Net) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Hemab Therapeutics Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344533
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 220,094 | 97,511 |
| Prepaid expenses and other current assets | 6,538 | 7,066 |
| Total current assets | 463,998 | 192,551 |
| Property and equipment, net | 596 | 609 |
| Operating right-of-use assets | 901 | 1,092 |
| Other non-current assets | 2,286 | 531 |
| Total assets | $467,781 | $194,783 |
| Liabilities, convertible preference shares, convertible preferred stock and stockholders’ equity (deficit) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Hemab Therapeutics Holdings, Inc.'s PP&E (net)?
- Hemab Therapeutics Holdings, Inc. (COAG) reported PP&E (net) of $596K in Q2 2026.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Hemab Therapeutics Holdings, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude